Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells.

Statistics:

The global stem cells market is estimated to account for US$ 9,941.2 Mn in terms of value in 2020 and is expected to reach US$ 18,289.9 Mn by the end of 2027.

Global Stem Cells Market: Drivers

Approval and launch of new products is expected to propel growth of the global stem cells market over the forecast period. For instance, in December 2019, BioRestorative Therapies, Inc. received a Notice of Allowance on its patent application for a method of generating brown fat stem cells from Israeli Patent Office. 

Moreover, increasing number of stem cell banking resource centers is also expected to aid in growth of the market. For instance, in March 2020, Stemlife Berhad, a cord blood bank in Malaysia, started a Stem Cell Banking Resource Center in Jerudong Park Medical Center, Brunei.

Statistics:

Adult stem cells held dominant position in the global stem cells market in 2019, accounting for 81.2% share in terms of value, followed by Human Embryonic Stem Cells and Induced Pluripotent Stem Cells, respectively

Figure 1. Global Stem Cells Market Share (%), by Value, by Cell Type, 2019.

Stem Cells  | Coherent Market Insights

Global Stem Cells Market: Restraints

High cost of stem cell therapy is expected to hinder growth of the global stem cells market. For instance, Bioinformant— a research firm engaged in stem cell research, reported that the cost of stem cell therapy ranges between US$ 5,000-8,000 per patient and in some cases it may rise as much as US$ 25,000 or more depending on the complexity of the procedure.     

Moreover, restrictions on research activities related to stem cells had hampered the growth of embryonic stem cells historically and resulted in its meager share in the total market in spite of its advantages over adult stem cells.

request-sample

Stem Cells Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 9,941.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 9.1% 2027 Value Projection: US$ 18,289.9 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Type: Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Natural Rosette Cells, Very Small Embryonic Like Stem Cells.
  • By Application: Regenerative Medicine, Drug Discovery and Development.
  • By Technology: Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture.
Companies covered:

Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc

Growth Drivers:
  • Increasing research and development
  • Increasing applications of regenerative medicine
Restraints & Challenges:
  • High costs
  • Lack of skilled professionals

Global Stem Cells Market: Opportunities 

R&D in stem cell donation is expected to offer lucrative growth opportunities for players in the global stem cells market. For instance, in March 2020, researchers from Dankook University and Catholic University, South Korea, reported investigation of the types and degrees of physical and psychological discomfort experienced by hematopoietic stem cell donors before, during, and after the donation process.

Moreover, adoption of online distribution channel is also expected to aid in growth of the global stem cells market. For instance, “The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions”, published in the journal Perspectives in Biology and Medicine, in 2018, the number of new stem cell businesses with websites doubled on average every year between 2009 and 2014, in the U.S.

The global stem cells market was valued at US$ 9,112.0 Mn in 2019 and is forecast to reach a value of US$ 18,289.9 Mn by 2027 at a CAGR of 9.1% between 2020 and 2027.

Figure 2. Global Stem Cells Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Stem Cells  | Coherent Market Insights

Market Trends/Key Takeaways

Adoption of stem cells for the treatment of various diseases is expected to propel growth of the global stem cells market. For instance, in January 2020, researchers at University of Houston developed biologic cardiac pacemaker-like cells by taking fat stem cells and reprogramming them as an alternative treatment for heart conditions such as conduction system disorders and heart attacks.

Moreover, increasing investment in stem cell therapies is also expected to aid in growth of the market. For instance, in July 2018, the Emory Orthopaedics & Spine Center, in collaboration with Sanford Health, Duke University, Andrews Institute, and Georgia Institute of Technology, received US$ 13 million grant from the Marcus Foundation for a multicenter clinical trial studying stem cell options for treating osteoarthritis. The Phase 3 trial was initiated in March 2019, and is expected to complete by December 2021.

Global Stem Cells Market: Competitive Landscape

Major players operating in the global stem cells market include, Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc.

Global Stem Cells Market: Key Developments

Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio. For instance, in September 2018, STEMCELL Technologies signed an exclusive license agreement with Brigham and Women’s Hospital for rights to commercialize technologies for the generation of human pluripotent stem cell-derived kidney organoids.

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.

Restraints of the Global Stem Cells Market

Major factors hampering the growth of the stem cells market during the forecast period constitutes of high costs, and lack of skilled professionals.

Key features of the study:

  • This report provides in-depth analysis of the global stem cells market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global stem cells market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Stem Cells Market, By Type:
    • Adult Stem Cells
    • Human Embryonic Stem Cells
    • Induced Pluripotent Stem Cells
    • Natural Rosette Cells
    • Very Small Embryonic Like Stem Cells
  • Global Stem Cells Market, By Application:
    • Regenerative Medicine
    • Drug Discovery and Development
  • Global Stem Cells Market, By Technology:
    • Cell Acquisition
    • Cell Production
    • Cryopreservation
    • Expansion and Sub-Culture
  • Global Stem Cells Market, By Geography:
    • North America
      • By Type
        • Adult Stem Cells
        • Human Embryonic Stem Cells
        • Induced Pluripotent Stem Cells
        • Natural Rosette Cells
        • Very Small Embryonic Like Stem Cells
      • By Application
        • Regenerative Medicine
        • Drug Discovery and Development
      • By Technology
        • Cell Acquisition
        • Cell Production
        • Cryopreservation
        • Expansion and Sub-Culture
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Type
        • Adult Stem Cells
        • Human Embryonic Stem Cells
        • Induced Pluripotent Stem Cells
        • Natural Rosette Cells
        • Very Small Embryonic Like Stem Cells
      • By Application
        • Regenerative Medicine
        • Drug Discovery and Development
      • By Technology
        • Cell Acquisition
        • Cell Production
        • Cryopreservation
        • Expansion and Sub-Culture
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • Adult Stem Cells
        • Human Embryonic Stem Cells
        • Induced Pluripotent Stem Cells
        • Natural Rosette Cells
        • Very Small Embryonic Like Stem Cells
      • By Application
        • Regenerative Medicine
        • Drug Discovery and Development
      • By Technology
        • Cell Acquisition
        • Cell Production
        • Cryopreservation
        • Expansion and Sub-Culture
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Type
        • Adult Stem Cells
        • Human Embryonic Stem Cells
        • Induced Pluripotent Stem Cells
        • Natural Rosette Cells
        • Very Small Embryonic Like Stem Cells
      • By Application
        • Regenerative Medicine
        • Drug Discovery and Development
      • By Technology
        • Cell Acquisition
        • Cell Production
        • Cryopreservation
        • Expansion and Sub-Culture
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Type
        • Adult Stem Cells
        • Human Embryonic Stem Cells
        • Induced Pluripotent Stem Cells
        • Natural Rosette Cells
        • Very Small Embryonic Like Stem Cells
      • By Application
        • Regenerative Medicine
        • Drug Discovery and Development
      • By Technology
        • Cell Acquisition
        • Cell Production
        • Cryopreservation
        • Expansion and Sub-Culture
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • Adult Stem Cells
        • Human Embryonic Stem Cells
        • Induced Pluripotent Stem Cells
        • Natural Rosette Cells
        • Very Small Embryonic Like Stem Cells
      • By Application
        • Regenerative Medicine
        • Drug Discovery and Development
      • By Technology
        • Cell Acquisition
        • Cell Production
        • Cryopreservation
        • Expansion and Sub-Culture
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Advanced Cell Technology, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Angel Biotechnology Holdings PLC
    • Bioheart Inc.
    • Lineage Cell Therapeutics
    • BrainStorm Cell Therapeutics, Inc.
    • California Stem Cell Inc.
    • Celgene Corporation
    • Takara Bio Europe AB
    • Cellular Engineering Technologies
    • Cytori Therapeutics Inc.
    • Osiris Therapeutics
    • STEMCELL Technologies Inc

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Application
      • Market Snippet, By Technology
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis
  4. Global Stem Cells Market, By Type, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Adult Stem Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Human Embryonic Stem Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Induced Pluripotent Stem Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Natural Rosette Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Very Small Embryonic Like Stem Cells
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Stem Cells Market, By Application, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Regenerative Medicine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Discovery and Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Stem Cells Market, By Technology, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Cell Acquisition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cell Production
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cryopreservation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Expansion and Sub-Culture
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Stem Cells Market, By Regions, 2016 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Advanced Cell Technology, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Angel Biotechnology Holdings PLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bioheart Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Lineage Cell Therapeutics
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • BrainStorm Cell Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • California Stem Cell Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Celgene Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Takara Bio Europe AB
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cellular Engineering Technologies
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cytori Therapeutics Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Osiris Therapeutics
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • STEMCELL Technologies Inc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 24 figures on “Stem Cells Market – Global forecast to 2027.

Frequently Asked Questions

The global stem cells market was valued at US$ 9,112.0 Mn in 2019 and is forecast to reach a value of US$ 18,289.9 Mn by 2027 at a CAGR of 9.1% between 2020 and 2027.
Major factor driving the growth of global stem cells market during the forecast period include increasing research and development, and increasing applications of regenerative medicine.
Major factors hampering the growth of the stem cells market during the forecast period constitutes of high costs, and lack of skilled professionals.
Adult stem cells held dominant position in the global stem cells market in 2019.
North America stem cells market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner